Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Teratogenicity01:07

Teratogenicity

2.4K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
2.4K
Development of Blood Vessels01:07

Development of Blood Vessels

562
The development of the vascular system in a fetus is a complex and intricate process that begins as early as 15 to 16 days post-conception. This process starts outside the embryo, specifically in the mesoderm of the yolk sac, chorion, and connecting stalk. Approximately two days later, the formation of blood vessels occurs within the embryo itself.
The initial formation of this system is facilitated by the small amount of yolk present in the ovum and yolk sac. Blood vessels originate from...
562
Cleavage and Blastulation01:33

Cleavage and Blastulation

45.0K
After a large-single-celled zygote is produced via fertilization, the process of cleavage occurs while zygotes travel through the uterine tube. Cleavage is a mitotic cell division that does not result in growth. With each round of successive cell division, daughter cells get increasingly smaller.
45.0K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Partial ectogestation and threats to the fetus: how healthcare professionals' caution may reinforce the medicalization of pregnancy and childbirth.

Journal of law and the biosciences·2025
Same author

Location, location, location: the approach of healthcare professionals in defining the artificially gestated entity.

Medical law review·2025
Same author

Editorial: In Honour of Professor Margaret Brazier: Memories of Margot.

Medical law review·2025
Same author

Respiratory Clinicians' Views on Offering "Rescue Packs" to Patients Discharged After COPD Exacerbation: Qualitative Interview Study.

COPD·2025
Same author

What Is an Identifier Good for? Issues in Using Visual Identifiers to Improve Care for People With Dementia in Hospital.

Journal of advanced nursing·2025
Same author

Legal fictions and complex lived realities: attributing legal parenthood in P V Q & F & X [2024] EWFC 85 (B)(FAM).

Medical law review·2025

相关实验视频

Updated: Jun 21, 2025

Mouse In Vivo Placental Targeted CRISPR Manipulation
07:39

Mouse In Vivo Placental Targeted CRISPR Manipulation

Published on: April 14, 2023

2.6K

死亡和人造胎盘

Anna Nelson1, Elizabeth Chloe Romanis2,3, Victoria Adkins4

  • 1School of Law, University of Sheffield, Sheffield, S3 7ND, UK.

Journal of law and the biosciences
|July 17, 2024
PubMed
概括
此摘要是机器生成的。

人工羊膜和胎盘技术 (AAPT) 为早产胎儿提供人工子宫. 目前的英国法律很难为AAPT支持的实体定义死亡,这对悲伤的父母造成了法律模两可.

关键词:
人工胎盘是一种人造的胎盘.人工子宫的人工子宫死亡死亡死亡死亡死亡死亡流产 流产 流产 流产一个死产的死产.

更多相关视频

Ex Vivo Perfusion of the Rodent Placenta
06:54

Ex Vivo Perfusion of the Rodent Placenta

Published on: May 30, 2019

9.8K
Determination of the Transport Rate of Xenobiotics and Nanomaterials Across the Placenta using the ex vivo Human Placental Perfusion Model
08:08

Determination of the Transport Rate of Xenobiotics and Nanomaterials Across the Placenta using the ex vivo Human Placental Perfusion Model

Published on: June 18, 2013

17.3K

相关实验视频

Last Updated: Jun 21, 2025

Mouse In Vivo Placental Targeted CRISPR Manipulation
07:39

Mouse In Vivo Placental Targeted CRISPR Manipulation

Published on: April 14, 2023

2.6K
Ex Vivo Perfusion of the Rodent Placenta
06:54

Ex Vivo Perfusion of the Rodent Placenta

Published on: May 30, 2019

9.8K
Determination of the Transport Rate of Xenobiotics and Nanomaterials Across the Placenta using the ex vivo Human Placental Perfusion Model
08:08

Determination of the Transport Rate of Xenobiotics and Nanomaterials Across the Placenta using the ex vivo Human Placental Perfusion Model

Published on: June 18, 2013

17.3K

科学领域:

  • 生物伦理学生物伦理学
  • 医疗法 法律 医疗法
  • 生殖技术 生殖技术

背景情况:

  • 人工胚胎和胎盘技术 (AAPT),或"人工子宫技术",使人类子宫外的胎儿继续发育.
  • 随着AAPT接近人类应用,其伦理和法律含义需要紧急澄清.

研究的目的:

  • 探索AAPT支持的实体死亡的法律特征.
  • 确定将现有法律框架应用于AAPT支持的实体的挑战.

主要方法:

  • 分析英格兰和威尔士现有的死亡判定法律标准,特别是对于早产或新生儿病例.
  • 检查这些标准对AAPT系统中的实体的适用性.

主要成果:

  • 目前英格兰和威尔士的法律标准不足以在AAPT的背景下明确地描述死亡.
  • 当试图将现有的法律框架应用于AAPT支持的实体时,会出现重大挑战.

结论:

  • 英格兰和威尔士的法律框架可能不足以解决AAPT的死亡决定的复杂性.
  • 在AAPT中,围绕死亡的法律模糊性可能会加剧父母的痛苦和不确定性.